The latest episode of the Debunked podcast explored an ongoing debate questioning the role of payers in healthcare transactions. It also highlighted turmoil at the CDC..

Corewell Health is demonstrating just how important it is to address the root causes of chronic disease. The Michigan-based health system released data this month showing that its partnership with ...

A federal judge has allowed key claims in Particle Health’s antitrust lawsuit against Epic to move forward, marking the first time such allegations against the EHR giant have gotten this far. The case ...

There is no biological measure for wakefulness. In a narcolepsy clinical trial, a patient lies down in a dark lab while clinicians count the minutes until sleep comes. The average time in four tests ...

WeightWatchers launched a new menopause-focused program on Monday, designed to support women with weight management from perimenopause through postmenopause. New York City-based WeightWatchers is a ...

A judge temporarily blocked key parts of a Trump rule that would have restricted access to Marketplace coverage, marking a legal victory for Democrats and healthcare advocates who argued the rule ...

The proposal, which would allow medical providers and private companies to share patient data more freely, has a laudable aim: to break down long-standing silos and speed the transition to AI-driven ...

A new survey reveals a growing dissatisfaction with so-called “healthcare navigators” who tend to work on behalf of health plans in favor of more independent, clinically integrated options. Two-thirds ...

Florida plans to end all vaccine mandates, drawing sharp criticism from health experts who warn it threatens public health and could lead to preventable disease outbreaks.

Lawmakers and health experts convened on Capitol Hill this week to discuss the use of AI in healthcare. They highlighted the technology’s potential to reduce administrative burdens and boost care ...

FDA Commissioner Marty Makary said publishing complete response letters recognizes public interest in the transparency and credibility of agency decision-making about drugs. He also said the move ...